Beijing Hotgen Biotech Co., Ltd. Stock: price and insider trades · China
热景生物
Beijing Hotgen Biotech Co., Ltd.: what insiders have been doing
Only a handful of insider records exist for Beijing Hotgen Biotech Co., Ltd., the last one from 13 July 2021, too few to describe a trend. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 327,333 shares100.0% of flowA股XSHGSSE:173000004560390050
1 of 1 declaration
About Beijing Hotgen Biotech Co., Ltd.
热景生物 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
